Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Sci Rep. 2022 May 12;12(1):7799. doi: 10.1038/s41598-022-11509-w.
Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks' gestation (January 1, 2009-December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24-27 weeks), median birth weight was 760 g (IQR, 620-918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks' gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP.
尽管早产儿死亡率较低,但日本需要治疗的早产儿视网膜病变(TR-ROP)患者比例较高。各种多中心研究已经报道了 TR-ROP 的危险因素;然而,日本尚未进行大规模研究。我们回顾性分析了 2009 年 1 月 1 日至 2018 年 12 月 31 日出生的 13645 名胎龄<28 周的婴儿,并在日本新生儿研究网络数据库中进行了登记。TR-ROP 定义为需要视网膜激光光凝和/或眼内抗血管内皮生长因子药物的 ROP。进行多变量逻辑回归分析以确定与 TR-ROP 发展相关的因素。纳入婴儿的中位胎龄为 26 周(四分位距[IQR],24-27 周),中位出生体重为 760 克(IQR,620-918 克)。TR-ROP 患者比例为 30.3%。TR-ROP 与胎龄<26 周(校正优势比[aOR] 1.54)、输血(aOR 1.49)、侵袭性通气≥28 天(aOR 1.41)、败血症(aOR 1.29)、出生体重<750 克(aOR 1.28)、脑室内出血(aOR 1.33)、全肠内喂养延迟达到>14 天(aOR 1.28)和持续气道正压通气(CPAP)治疗≥28 天(aOR 0.79)显著相关。补充氧气≥28 天与 TR-ROP 发展无关。较低的出生胎龄和出生体重、输血、延长的侵袭性通气、败血症、脑室内出血和全肠内喂养延迟是 TR-ROP 的危险因素,而 CPAP 应用可预防 TR-ROP。